This is the use case where AOD-9604 has the most appeal but potentially the least clinical data to support it
Other side effects Additional reported side effects include: Joint pain and water retention Muscle and joint aches Headaches and nausea Receptor desensitization with prolonged use Potential suppression of natural GH and IGF-1 production Who should avoid IGF-1 LR3 Certain groups should not use IGF-1 LR3: Anyone with active cancer or tumor history Those with severe insulin resistance or diabetes Pregnant or nursing women Anyone under 25 whose growth plates haven't closed Those with existing hormonal imbalances IGF-1 LR3 is not FDA-approved for general medical use and remains primarily a research compound
Level of Evidence: 3 Thermodynamically stable ionic liquid microemulsions pioneer pathways for topical delivery and peptide application Type of study: non-rct in vitro Number of citations: 10 Year: 2023 Authors: Tian-Hu Liu, Ying Liu, Xiaoyu Zhao, Liguo Zhang, Wei Wang, De Bai, Y
HIV and lipodystrophy
Generally, it takes less than 45 minutes to complete the infusion
Holm SK, Johansen VBI, Clemmensen C
